Remedy Robotics is a pioneering company focused on tackling the critical challenges posed by cardiovascular diseases, which stand as the leading cause of morbidity and mortality worldwide. The company is at the forefront of medical innovation, developing the world's first remotely-operated, semi-autonomous endovascular surgical robot designed to facilitate life-saving procedures from significant distances. This groundbreaking technology has already been validated through successful first-in-human cases, highlighting its potential to transform medical interventions in hospitals that lack specialized surgical services. With a diverse and multidisciplinary team comprising medical clinicians, roboticists, and machine learning experts, Remedy Robotics is dedicated to ensuring that state-of-the-art vascular interventions are accessible to patients, irrespective of their geographical barriers.